These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Mechanisms by which the surface expression of the glycosyl-phosphatidylinositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines. Hatanaka M; Seya T; Matsumoto M; Hara T; Nonaka M; Inoue N; Takeda J; Shimizu A Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):969-76. PubMed ID: 8615796 [TBL] [Abstract][Full Text] [Related]
6. Paroxysmal nocturnal hemoglobinuria in children. van den Heuvel-Eibrink MM Paediatr Drugs; 2007; 9(1):11-6. PubMed ID: 17291133 [TBL] [Abstract][Full Text] [Related]
9. Deficient surface expression of glycosylphosphatidylinositol-anchored proteins in B cell lines established from patients with paroxysmal nocturnal hemoglobinuria. Ueda E; Nishimura J; Kitani T; Nasu K; Kageyama T; Kim YU; Takeda J; Kinoshita T Int Immunol; 1992 Nov; 4(11):1263-71. PubMed ID: 1282030 [TBL] [Abstract][Full Text] [Related]
10. Expression of glycosyl-phosphatidylinositol-linked glycoproteins in blood cells from paroxysmal nocturnal haemoglobinuria patients: a flow cytometry study using CD55, CD58 and CD59 monoclonal antibodies. Navenot JM; Bernard D; Harousseau JL; Muller JY; Blanchard D Leuk Lymphoma; 1996 Mar; 21(1-2):143-51. PubMed ID: 8907282 [TBL] [Abstract][Full Text] [Related]
11. Congenital Defects in the Expression of the Glycosylphosphatidylinositol-Anchored Complement Regulatory Proteins CD59 and Decay-Accelerating Factor. Kinoshita T Semin Hematol; 2018 Jul; 55(3):136-140. PubMed ID: 30032750 [TBL] [Abstract][Full Text] [Related]
12. Preferential expression of human Fc gamma RIIIPMN (CD16) in paroxysmal nocturnal hemoglobinuria. Discordant expression of glycosyl phosphatidylinositol-linked proteins. Edberg JC; Salmon JE; Whitlow M; Kimberly RP J Clin Invest; 1991 Jan; 87(1):58-67. PubMed ID: 1702101 [TBL] [Abstract][Full Text] [Related]
13. Correction of the PNH defect by GPI protein transfer: still an open question. Bütikofer P Blood; 2000 Mar; 95(5):1876-8. PubMed ID: 10744388 [No Abstract] [Full Text] [Related]
14. [Paroxysmal nocturnal hemoglobinuria (PNH) as a hematopoietic stem cell disorder--long-term support of hematopoiesis by a single stem cell clone in patients with PNH]. Hirota T Rinsho Ketsueki; 2002 Apr; 43(4):215-22. PubMed ID: 12043194 [No Abstract] [Full Text] [Related]
17. Decay-accelerating-factor-deficient erythrocytes during the long-term clinical course of patients with paroxysmal nocturnal hemoglobinuria. Mahbub B; Nishimura J; Kitani T; Kitano K Acta Haematol; 1995; 93(2-4):91-7. PubMed ID: 7543722 [TBL] [Abstract][Full Text] [Related]
18. Analysis of PIG-A gene in a patient who developed reciprocal translocation of chromosome 12 and paroxysmal nocturnal hemoglobinuria during follow-up of aplastic anemia. Nishimura JI; Inoue N; Azenishi Y; Hirota T; Akaogi T; Shibano M; Kawagoe K; Ueda E; Machii T; Takeda J Am J Hematol; 1996 Mar; 51(3):229-33. PubMed ID: 8619404 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of mannosylglucosaminylinositol phospholipids in normal but not paroxysmal nocturnal hemoglobinuria cells. Hirose S; Ravi L; Prince GM; Rosenfeld MG; Silber R; Andresen SW; Hazra SV; Medof ME Proc Natl Acad Sci U S A; 1992 Jul; 89(13):6025-9. PubMed ID: 1378620 [TBL] [Abstract][Full Text] [Related]
20. [Clinical features and diagnosis of paroxysmal nocturnal hemoglobinuria: correlates with the deficiency of GPI-anchored membrane proteins]. Ninomiya H Rinsho Ketsueki; 1994 Apr; 35(4):352-7. PubMed ID: 7518013 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]